After a transgender woman stops estradiol and spironolactone, how long does it take to regain spermatogenesis and produce sperm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Recovery of Spermatogenesis After Stopping Estradiol and Spironolactone

The timeline for sperm production recovery after stopping feminizing hormone therapy is highly variable and uncertain, but based on available evidence, you should expect a median recovery time of approximately 3-4 months to reach fertility-relevant sperm counts, though complete recovery may take 12-24 months or potentially longer—and importantly, restoration of spermatogenesis after prolonged estrogen treatment has not been adequately studied.

Critical Evidence Gap

The most important finding from guideline evidence is that "restoration of spermatogenesis after prolonged estrogen treatment has not been studied" 1. This represents a significant knowledge gap specific to transgender women discontinuing feminizing hormone therapy.

Expected Timeline Based on Related Evidence

While direct data are lacking, extrapolation from male contraceptive studies provides the best available framework:

  • Median time to 20 million sperm/mL: 3.4 months (95% CI 3.2-3.5)
  • Probability of recovery to 20 million sperm/mL:
    • 67% within 6 months
    • 90% within 12 months
    • 96% within 16 months
    • 100% within 24 months 2

However, these data come from hormonal male contraception studies in cisgender men, not transgender women on feminizing therapy, so direct applicability is uncertain.

Factors That Affect Recovery Time

Several variables influence how quickly—or whether—spermatogenesis returns:

Age: Older individuals recover more slowly. In testosterone-related suppression studies, increasing age significantly reduced likelihood of sperm recovery at both 6 and 12 months 3.

Duration of hormone therapy: Longer exposure to feminizing hormones correlates with delayed recovery. One study found duration of testosterone use directly correlated with time to sperm recovery, though this effect was less pronounced at 12 months than at 6 months 3.

Type of antiandrogen matters significantly: Recent 2026 data show that spironolactone preserves spermatogenesis much better than other antiandrogens. Among transgender women on feminizing therapy, 53.3% taking spironolactone maintained active spermatogenesis versus only 8.7% taking cyproterone acetate 4. This suggests recovery may be faster after spironolactone-based regimens.

Baseline testicular function: Pre-existing semen quality affects recovery potential. Notably, only 46.9% of treatment-naïve transgender individuals met WHO normozoospermia criteria before starting any hormone therapy, compared to 75.5% of cisgender controls 5.

Risk of Permanent Impairment

The guideline explicitly warns that "prolonged exposure of the testes to estrogen has been associated with testicular damage" 1. This raises concern about irreversible effects, though the threshold for "prolonged" is not defined.

Contemporary literature suggests that in some men with hormone-induced suppression, "drug cessation alone may not achieve spontaneous recovery, necessitating hormonal stimulation with selective estrogen receptor modulators (SERMs)/gonadotropin therapy or even the need for assisted reproductive techniques" 6.

Clinical Approach

Given the uncertainty and individual variability:

  1. Counsel that recovery is possible but not guaranteed, with most recovery occurring within 3-12 months if it occurs at all

  2. Monitor semen analysis starting at 3 months post-cessation, then every 3 months until recovery plateaus

  3. Consider medical intervention if no recovery by 6-12 months: This may include clomiphene citrate (SERM) or hCG/FSH therapy to stimulate spermatogenesis, though evidence for efficacy in this specific population is limited 6

  4. Set realistic expectations: Recovery of sperm output occurs around 14 months on average in androgen-suppression studies, but sperm motility may take up to 38 months 7

Critical Pitfall

The most important caveat is that fertility preservation should ideally occur before starting feminizing hormone therapy 1. The guideline strongly recommends that "all transsexual individuals be informed and counseled regarding options for fertility before initiation of...treatment with sex hormones" 1. Once hormone therapy has been prolonged, the ability to recover fertility becomes increasingly uncertain and potentially compromised.

References

1
Guideline

endocrine treatment of transsexual persons: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2009

7
Research

Androgens and spermatogenesis.

Annales d'endocrinologie, 2022

Related Questions

What is the differential diagnosis, appropriate work‑up, and management for a 22‑year‑old woman with markedly low progesterone (<0.5 ng/mL) and low estradiol (<30 pg/mL)?
What is the appropriate evaluation and management for a 48-year-old woman with a markedly elevated estradiol level of 1464 pg/mL?
For a 56-year-old woman using a transdermal estradiol 0.075 mg/24 h patch twice weekly but currently changing it every 2 days, is this frequency too frequent and will it raise her serum estradiol level?
How should I evaluate and manage a 56-year-old man not on testosterone who has an elevated estradiol level?
What oral estradiol dose per day is equivalent to a 0.1 mg (100 µg) transdermal estradiol patch?
What are the newest second-generation antipsychotics and their approved indications?
What is the appropriate follow‑up for a patient previously treated for syphilis with a positive rapid plasma reagin (RPR) who now has an RPR titer of 1:8 after receiving an additional 2.4 million units of benzathine penicillin G intramuscularly?
What is the Strasberg classification of bile duct injuries and how does each grade typically present clinically?
In a patient with decompensated chronic liver disease (DCLD) with ascites and deranged liver function tests, which analgesic is preferred for severe back pain: tramadol or paracetamol?
For a diabetic patient currently taking losartan 50 mg daily, is there a smaller dose available for the initial dose increase?
What over-the-counter medications are recommended for rheumatoid arthritis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.